Pharmaceutical Industry Reports

Reports > Pharmaceutical > Selected Report

Global Oral Solid Dosage Pharmaceutical Formulation Market Report for Period 2017 till 2023

Single User: $0
Multiple User: $0
Enterprise User: $0


Report Summary:

In this report, the global Oral Solid Dosage Pharmaceutical Formulation market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Oral Solid Dosage Pharmaceutical Formulation in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
China
Japan
Southeast Asia
India
Global Oral Solid Dosage Pharmaceutical Formulation market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
AstraZeneca Plc.
Bristol-Myers Squibb Company
Eli Lilly and Company
Gilead Sciences
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
AbbVie Inc.
Boehringer Ingelheim GmbH
Hoffman-La-Roche Ltd.
Johnson & Johnson
Biogen Inc.
Bayer AG
Teva Pharmaceticals
Amgen Inc.
Takeda Pharmaceutical Company Ltd.
Otsuka Pharmaceutical Co., Ltd.
Shire Plc.
Celgene Corporation
Astellas Pharma Inc.
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
By Form
Capsules
Powders
Tablets
By Drug Release Mechanism
Immediate Release
Extended Release
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospitals
Clinics
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents / Index:

Table of Contents

Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2017
1 Oral Solid Dosage Pharmaceutical Formulation Market Overview
1.1 Product Overview and Scope of Oral Solid Dosage Pharmaceutical Formulation
1.2 Oral Solid Dosage Pharmaceutical Formulation Segment By Form
1.2.1 Global Oral Solid Dosage Pharmaceutical Formulation Production and CAGR (%) Comparison By Form (Product Category)(2012-2022)
1.2.2 Global Oral Solid Dosage Pharmaceutical Formulation Production Market Share By Form (Product Category) in 2016
1.2.3 Capsules
1.2.4 Powders
1.2.5 Tablets
1.3 Oral Solid Dosage Pharmaceutical Formulation Segment By Drug Release Mechanism
1.3.1 Immediate Release
1.3.2 Extended Release
1.4 Global Oral Solid Dosage Pharmaceutical Formulation Segment by Application
1.4.1 Oral Solid Dosage Pharmaceutical Formulation Consumption (Sales) Comparison by Application (2012-2022)
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Other
1.5 Global Oral Solid Dosage Pharmaceutical Formulation Market by Region (2012-2022)
1.5.1 Global Oral Solid Dosage Pharmaceutical Formulation Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.5.2 North America Status and Prospect (2012-2022)
1.5.3 Europe Status and Prospect (2012-2022)
1.5.4 China Status and Prospect (2012-2022)
1.5.5 Japan Status and Prospect (2012-2022)
1.5.6 Southeast Asia Status and Prospect (2012-2022)
1.5.7 India Status and Prospect (2012-2022)
1.6 Global Market Size (Value) of Oral Solid Dosage Pharmaceutical Formulation (2012-2022)
1.6.1 Global Oral Solid Dosage Pharmaceutical Formulation Revenue Status and Outlook (2012-2022)
1.6.2 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production Status and Outlook (2012-2022)

2 Global Oral Solid Dosage Pharmaceutical Formulation Market Competition by Manufacturers
2.1 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Production and Share by Manufacturers (2012-2017)
2.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Share by Manufacturers (2012-2017)
2.3 Global Oral Solid Dosage Pharmaceutical Formulation Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Oral Solid Dosage Pharmaceutical Formulation Manufacturing Base Distribution, Sales Area and Product Type
2.5 Oral Solid Dosage Pharmaceutical Formulation Market Competitive Situation and Trends
2.5.1 Oral Solid Dosage Pharmaceutical Formulation Market Concentration Rate
2.5.2 Oral Solid Dosage Pharmaceutical Formulation Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue (Value) by Region (2012-2017)
3.1 Global Oral Solid Dosage Pharmaceutical Formulation Capacity and Market Share by Region (2012-2017)
3.2 Global Oral Solid Dosage Pharmaceutical Formulation Production and Market Share by Region (2012-2017)
3.3 Global Oral Solid Dosage Pharmaceutical Formulation Revenue (Value) and Market Share by Region (2012-2017)
3.4 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.5 North America Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.6 Europe Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.7 China Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Japan Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.9 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
3.10 India Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Oral Solid Dosage Pharmaceutical Formulation Supply (Production), Consumption, Export, Import by Region (2012-2017)
4.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption by Region (2012-2017)
4.2 North America Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)
4.3 Europe Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)
4.4 China Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)
4.5 Japan Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)
4.7 India Oral Solid Dosage Pharmaceutical Formulation Production, Consumption, Export, Import (2012-2017)

5 Global Oral Solid Dosage Pharmaceutical Formulation Production, Revenue (Value), Price Trend by Type
5.1 Global Oral Solid Dosage Pharmaceutical Formulation Production and Market Share by Type (2012-2017)
5.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Market Share by Type (2012-2017)
5.3 Global Oral Solid Dosage Pharmaceutical Formulation Price by Type (2012-2017)
5.4 Global Oral Solid Dosage Pharmaceutical Formulation Production Growth by Type (2012-2017)

6 Global Oral Solid Dosage Pharmaceutical Formulation Market Analysis by Application
6.1 Global Oral Solid Dosage Pharmaceutical Formulation Consumption and Market Share by Application (2012-2017)
6.2 Global Oral Solid Dosage Pharmaceutical Formulation Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Oral Solid Dosage Pharmaceutical Formulation Manufacturers Profiles/Analysis
7.1 AstraZeneca Plc.
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 AstraZeneca Plc. Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.1.4 Main Business/Business Overview
7.2 Bristol-Myers Squibb Company
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol-Myers Squibb Company Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.2.4 Main Business/Business Overview
7.3 Eli Lilly and Company
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Eli Lilly and Company Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.3.4 Main Business/Business Overview
7.4 Gilead Sciences
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Gilead Sciences Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.4.4 Main Business/Business Overview
7.5 Merck & Co. Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Merck & Co. Inc. Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.5.4 Main Business/Business Overview
7.6 Novartis AG
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Novartis AG Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.6.4 Main Business/Business Overview
7.7 Pfizer Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Pfizer Inc. Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.7.4 Main Business/Business Overview
7.8 AbbVie Inc.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 AbbVie Inc. Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.8.4 Main Business/Business Overview
7.9 Boehringer Ingelheim GmbH
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Boehringer Ingelheim GmbH Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.9.4 Main Business/Business Overview
7.10 Hoffman-La-Roche Ltd.
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Oral Solid Dosage Pharmaceutical Formulation Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Hoffman-La-Roche Ltd. Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue, Price and Gross Margin (2012-2017)
7.10.4 Main Business/Business Overview
7.11 Johnson & Johnson
7.12 Biogen Inc.
7.13 Bayer AG
7.14 Teva Pharmaceticals
7.15 Amgen Inc.
7.16 Takeda Pharmaceutical Company Ltd.
7.17 Otsuka Pharmaceutical Co., Ltd.
7.18 Shire Plc.
7.19 Celgene Corporation
7.20 Astellas Pharma Inc.

8 Oral Solid Dosage Pharmaceutical Formulation Manufacturing Cost Analysis
8.1 Oral Solid Dosage Pharmaceutical Formulation Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Oral Solid Dosage Pharmaceutical Formulation

9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Oral Solid Dosage Pharmaceutical Formulation Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Oral Solid Dosage Pharmaceutical Formulation Major Manufacturers in 2015
9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List

11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 Global Oral Solid Dosage Pharmaceutical Formulation Market Forecast (2017-2022)
12.1 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production, Revenue Forecast (2017-2022)
12.1.1 Global Oral Solid Dosage Pharmaceutical Formulation Capacity, Production and Growth Rate Forecast (2017-2022)
12.1.2 Global Oral Solid Dosage Pharmaceutical Formulation Revenue and Growth Rate Forecast (2017-2022)
12.1.3 Global Oral Solid Dosage Pharmaceutical Formulation Price and Trend Forecast (2017-2022)
12.2 Global Oral Solid Dosage Pharmaceutical Formulation Production, Consumption , Import and Export Forecast by Region (2017-2022)
12.2.1 North America Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.2 Europe Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.3 China Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.4 Japan Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.5 Southeast Asia Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.2.6 India Oral Solid Dosage Pharmaceutical Formulation Production, Revenue, Consumption, Export and Import Forecast (2017-2022)
12.3 Global Oral Solid Dosage Pharmaceutical Formulation Production, Revenue and Price Forecast by Type (2017-2022)
12.4 Global Oral Solid Dosage Pharmaceutical Formulation Consumption Forecast by Application (2017-2022)

13 Research Findings and Conclusion

14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer


Research Methodology

The market research report added recently to collection of Market Reports Company is based on detailed qualitative and quantitative analysis. The research report is a blend of both bottom up and top down research with the help of which quantitative aspects of the market are determined. Besides this various statistical models, projection techniques and sampling techniques are implemented for quantitative analysis.
The qualitative analysis includes through interactive study with all major industry participants across the industrial value chain. The analysis includes extensive interviews with raw material suppliers, experienced front line staff, directors, CEOs, distributors, major manufacturers, industry experts and end-users. Interaction are usually done with the help of primary interviews, surveys, and vendor briefings. All major factors that influence this market are studied in this research report. The market size for top level markets and sub-segments is normalized, and the impact of various macro and micro economic factors are analyzed during market forecast.

Secondary Research
Secondary sources play a vital role in collection of raw data. Various paid and open access data sources are referred for collection for secondary data. Some of the major secondary data sources referred include:

■ Press releases, annual reports, Non-Profit organizations
■ Industry associations, governmental agencies and customs data
■ Directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), etc.

Primary Research
In Primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Some of the major primary sources include:

■ Product manufacturers
■ Opinion leaders, industry experts and research institutions
■ Distributors, Dealer and Traders
■ Raw Materials suppliers and producers etc.

The data collected through secondary research is validated with the help of primary research respondents.

Data Models
Wherever no credible data sources are available, various data models are implemented which help to develop wide data sets.

Request a Sample of this Report

Please fill out the details requested below.
Our representative will contact you within 1 hour.


Name:


Email ID:


Name of Company:


Designation/Role:


Country:


Message:


Please Enter Captcha Below:

Report Details:



Report ID: 37982

Category: 16

Published date: 2017-12-03 20:12:16

Number of Pages: 115

Publisher Name:

Over all Rating: 0 % (Average of Ratings provided by clients)